Evidence map›Paper›PMID 37534488›Full record

ReviewRecent patents on anti-cancer drug discovery2024

Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review.

Seyed Mahdi Zarezadeh, Amir Mohammad Sharafi, Gisou Erabi, Arefeh Tabashiri, Navid Teymouri, Hoda Mehrabi, Seyyed Amirhossein Golzan, Arezoo Faridzadeh, Zahra Abdollahifar, Nafiseh Sami and 8 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on anti-cancer drug discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Seyed Mahdi ZarezadehStudents' Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6187-7277
Amir Mohammad SharafiStudents' Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-8284-3540
Gisou ErabiStudent Research Committee, Urmia University of Medical Sciences, Urmia, Iran.ORCID 0000-0001-6422-4474
Arefeh TabashiriStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0740-238X
Navid TeymouriStudent Research Committee, Tabriz University of Medical Science, Tabriz, Iran.ORCID 0000-0003-3136-8871
Hoda MehrabiStudent Research Committee, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-8991-3273
Seyyed Amirhossein GolzanStudent Research Committee, Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9233-685X
Arezoo FaridzadehDepartment of Immunology and Allergy, Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-9094-6999
Zahra AbdollahifarStudent Research Committee, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0002-1761-8515
Nafiseh SamiStudent Research Committee, Tehran Medical Sciences, Islamic Azad University Medical Branch of Tehran, Tehran, Iran.ORCID 0000-0001-8453-1949
Javad ArabpourDepartment of Microbiology, Faculty of New Sciences, Islamic Azad University Medical Branch of Tehran, Tehran, Iran.ORCID 0000-0002-9968-0231
Zahra RahimiSchool of Medicine, Zanjan University of Medical Sciences Zanjan, Iran.ORCID 0000-0003-0698-0137
Arina AnsariStudent Research Committee, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.ORCID 0000-0003-2625-9603
Mohammad Reza AbbasiBabol University of Medical Sciences, Babol, Iran.ORCID 0000-0002-5764-1031
Nima AziziStudents' Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5900-428X
Amirhossein TamimiSchool of Medicine, Guilan University of Medical Sciences, Rasht, Iran.ORCID 0000-0002-0228-3409
Mohadeseh PoudinehSchool of Medicine, Zanjan University of Medical Sciences Zanjan, Iran.
Niloofar DeraviStudent Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6965-6927

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is one of the leading causes of mortality and morbidity worldwide, affecting millions of people physically and financially every year. Over time, many anticancer treatments have been proposed and studied, including synthetic compound consumption, surgical procedures, or grueling chemotherapy. Although these treatments have improved the daily life quality of patients and increased their survival rate and life expectancy, they have also shown significant drawbacks, including staggering costs, multiple side effects, and difficulty in compliance and adherence to treatment. Therefore, natural compounds have been considered a possible key to overcoming these problems in recent years, and thorough research has been done to assess their effectiveness. In these studies, scientists have discovered a meaningful interaction between several natural materials and signal transducer and activator of transcription 3 molecules. STAT3 is a transcriptional protein that is vital for cell growth and survival. Mechanistic studies have established that activated STAT3 can increase cancer cell proliferation and invasion while reducing anticancer immunity. Thus, inhibiting STAT3 signaling by natural compounds has become one of the favorite research topics and an attractive target for developing novel cancer treatments. In the present article, we intend to comprehensively review the latest knowledge about the effects of various organic compounds on inhibiting the STAT3 signaling pathway to cure different cancer diseases.

Indexed as

NeoplasmsSignal TransductionSTAT3 Transcription FactorAnimalsAntineoplastic AgentsBiological ProductsHumansPatents as TopicAntineoplastic AgentsBiological ProductsSTAT3 protein, humanSTAT3 Transcription Factoranticancerchemotherapy.herbal medicineischemic heart diseasenatural medicineSTAT3

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.